The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial

被引:0
作者
Chris Dalby
Tomasz Polanowski
Thomas Larsson
Lars Borgström
Staffan Edsbäcker
Tim W Harrison
机构
[1] Nottingham University,Respiratory Medicine Unit
[2] AstraZeneca R&D,undefined
来源
Respiratory Research | / 10卷
关键词
Chronic Obstructive Pulmonary Disease; Chronic Obstructive Pulmonary Disease Patient; Budesonide; Fluticasone; Fluticasone Propionate;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
empty
未找到相关数据